Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024		Jun. 30, 2025	Jun. 30, 2024
Revenue	$ 24,215	$ 21,848		$ 44,469	$ 40,629
Cost of revenue	3,550	2,229		5,880	3,957
Gross profit	20,665	19,619		38,589	36,672
Operating expenses:
Research and development expenses	18,914	15,402		38,785	30,896
Selling, general and administrative expenses	43,199	30,056		78,166	57,355
Operating loss	(41,448)	(25,839)		(78,362)	(51,579)
Financing on prepaid forward obligation	(4,644)	(5,773)		(9,227)	(11,433)
Interest expense on long-term debt	(4,132)	(3,461)		(8,200)	(5,908)
Interest and other income, net	1,299	1,708		3,413	3,323
Loss before income taxes	(48,925)	(33,365)		(92,376)	(65,597)
Income tax expense	(1,015)	(38)		(1,407)	(92)
Net Loss	(49,940)	(33,403)		(93,783)	(65,689)
Statements of Comprehensive Loss
Net loss	(49,940)	(33,403)		(93,783)	(65,689)
Other comprehensive loss
Unrealized income (loss) on investments	(8)	6		(50)	(43)
Comprehensive Loss	$ (49,948)	$ (33,397)		$ (93,833)	$ (65,732)
Net loss per ordinary share - basic and diluted (in dollars per share)	$ (1.05)	$ (0.82)	[1]	$ (1.97)	$ (1.69)	[1]
Weighted average number of shares outstanding used in computation of basic and diluted loss per ordinary share (in shares)	47,739,816	40,501,315	[1]	47,582,610	38,785,924	[1]

[1] The loss per share, both basic and diluted, for the second quarter of 2024 was revised to record an immaterial correction to the amounts originally reported in the June 30, 2024 Form 10-Q filed on August 13, 2024 by incorporating the 3,679,400 shares of pre-funded warrants outstanding as of the reporting period, which were not included in the previous calculations and are now reflected in the weighted average shares outstanding.